- Home
- STEM vs SAVA Comparison
STEM vs SAVA Comparison
Compare STEM & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- SAVA
- Stock Information
- Founded
- STEM 2009
- SAVA 1998
- Country
- STEM United States
- SAVA United States
- Employees
- STEM N/A
- SAVA N/A
- Industry
- STEM Computer Software: Prepackaged Software
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- STEM Technology
- SAVA Health Care
- Exchange
- STEM Nasdaq
- SAVA Nasdaq
- Market Cap
- STEM 135.7M
- SAVA 135.9M
- IPO Year
- STEM N/A
- SAVA N/A
- Fundamental
- Price
- STEM $0.70
- SAVA $2.75
- Analyst Decision
- STEM Hold
- SAVA Buy
- Analyst Count
- STEM 8
- SAVA 3
- Target Price
- STEM $1.38
- SAVA $111.50
- AVG Volume (30 Days)
- STEM 25.4M
- SAVA 3.4M
- Earning Date
- STEM 02-26-2025
- SAVA 02-26-2025
- Dividend Yield
- STEM N/A
- SAVA N/A
- EPS Growth
- STEM N/A
- SAVA N/A
- EPS
- STEM N/A
- SAVA N/A
- Revenue
- STEM $256,183,000.00
- SAVA N/A
- Revenue This Year
- STEM N/A
- SAVA N/A
- Revenue Next Year
- STEM $130.56
- SAVA N/A
- P/E Ratio
- STEM N/A
- SAVA N/A
- Revenue Growth
- STEM N/A
- SAVA N/A
- 52 Week Low
- STEM $0.30
- SAVA $2.23
- 52 Week High
- STEM $3.58
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- STEM 51.79
- SAVA 30.54
- Support Level
- STEM $0.57
- SAVA $2.65
- Resistance Level
- STEM $0.92
- SAVA $2.83
- Average True Range (ATR)
- STEM 0.23
- SAVA 0.24
- MACD
- STEM -0.02
- SAVA 0.59
- Stochastic Oscillator
- STEM 24.90
- SAVA 52.75
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on innovative technology services that transform the way energy is distributed and consumed.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.